Package 70518-2772-2

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 70518-2772-2
Digits Only 7051827722
Product NDC 70518-2772
Product ID 70518-2772_4a8ffecf-04a6-5dd0-e063-6294a90a974d
Description

90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2772-2)

Marketing

Marketing Status
Marketed Since 2022-02-26
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4a8ffecf-04a6-5dd0-e063-6294a90a974d", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["e187f83e-ee5e-46d9-9b4f-7e818d16776d"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2772-2)", "package_ndc": "70518-2772-2", "marketing_start_date": "20220226"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "70518-2772_4a8ffecf-04a6-5dd0-e063-6294a90a974d", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "70518-2772", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20200608", "listing_expiration_date": "20271231"}